Arterial thrombosis associated with adjuvant chemotherapy for breast carcinoma: a Cancer and Leukemia Group B Study

The American Journal of Medicine
J G WallW C Wood

Abstract

Multiagent chemotherapy and chemohormonal therapy for breast cancer are associated with an increased risk for venous thromboembolic complications. We observed instances of arterial thrombosis in two studies of breast cancer involving multiagent chemotherapy for stages II and III disease. Our purpose in this study was to determine the incidence of this complication and whether it appeared to be related to the chemotherapy or was a random event. Episodes of arterial thrombotic events were identified from record reviews of 1,014 assessable patients with breast cancer entered on two Cancer and Leukemia Group B protocols. Details of the kind of arterial event, when it occurred, the outcome, and the occurrence of metastases were analyzed. Thirteen (1.3%) patients had an arterial thrombosis: six (5.3%) of 113 patients with stage III disease and seven (0.8%) of 901 patients with stage II disease. Four of these patients had a peripheral arterial thrombosis and nine had strokes (four were fatal). All these events occurred while the patients were receiving adjuvant chemotherapy. Only one additional arterial event (a stroke approximately four years later) has occurred in this patient group after chemotherapy was completed. Arterial thrombo...Continue Reading

Citations

Oct 31, 2002·Neoplasia : an International Journal for Oncology Research·Graham J CaineSean T Kehoe
Nov 1, 1990·Clinical & Experimental Metastasis·M C BertomeuM R Buchanan
Nov 1, 1992·Cancer Metastasis Reviews·F R RicklesR L Edwards
Nov 1, 1992·Cancer Metastasis Reviews·L V Rao
Apr 25, 2000·Annual Review of Medicine·G Hortobagyi
Nov 1, 1995·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·F MaggioniG Zanchin
Jun 13, 2006·Archives of Gynecology and Obstetrics·Kazuhide HidaHiroaki Ohta
Jan 11, 1992·Cancer Investigation·G W Sledge, W McCaskill-Stevens
Jul 6, 2010·Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association·Shihab MasrurLee H Schwamm
Jan 30, 2007·La Presse médicale·Eric VoogLaurence Juhel
Mar 20, 2010·Journal of the American Academy of Nurse Practitioners·Laura Bourdeanu, Thehang Luu
May 1, 1992·The American Journal of Medicine·W W WongR R Weichselbaum
Sep 1, 1992·American Heart Journal·J E NaschitzJ Abrahamson
Feb 5, 2005·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Greger NilssonCarl Blomqvist
May 1, 1995·Cancer Treatment Reviews·E A Lowenthal, J T Carpenter
Feb 14, 2006·Seminars in Oncology·Nasir ShahabDonald C Doll
Apr 1, 1996·Hematology/oncology Clinics of North America·K E Goad, H R Gralnick
Apr 15, 2003·Neurologic Clinics·Lisa R Rogers
Jan 18, 2006·Clinical Neurology and Neurosurgery·Shau-Hsuan LiCheng-Hua Huang
Jul 26, 2005·Critical Reviews in Oncology/hematology·Mario CamponeHenri Roché
Oct 21, 2004·Journal of the National Cancer Institute·Ann M GeigerLeslie Bernstein
Dec 16, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Diana CrivellariUNKNOWN International Breast Cancer Study Group
Mar 22, 2000·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·G F von TempelhoffL Heilmann
Oct 10, 2003·Cancer·Graham J CaineGregory Y H Lip
May 31, 2002·Internal Medicine Journal·J B SelvanayagamR J McRitchie
Aug 1, 1990·Stroke; a Journal of Cerebral Circulation·R G Hart, M C Kanter
Sep 26, 2013·Stroke; a Journal of Cerebral Circulation·Santosh B MurthyJose I Suarez
Jul 19, 2012·Journal of breast cancer·Vasiliki Kyriazi
Jan 1, 1996·Breast Cancer Research and Treatment·C RellaF Schittulli
Jan 11, 2019·International Journal of Oncology·Efthimios DardiotisAristidis Tsatsakis
Sep 3, 2020·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Marwa S Hamza, Shaker A Mousa
Sep 1, 1991·Seminars in Surgical Oncology·J Crown, L Norton
May 16, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·N I WeijlS Osanto
Feb 20, 2021·Scientific Reports·Hyun-Keun KwonByung-Joo Lee
Jun 20, 2003·Circulation·Agnes Y Y Lee, Mark N Levine

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.